156 related articles for article (PubMed ID: 33455296)
1. The Effect of Counterions in Hydrophobic Ion Pairs on Oral Bioavailability of Exenatide.
Phan TNQ; Ismail R; Le-Vinh B; Zaichik S; Laffleur F; Bernkop-Schnürch A
ACS Biomater Sci Eng; 2020 Sep; 6(9):5032-5039. PubMed ID: 33455296
[TBL] [Abstract][Full Text] [Related]
2. In vivo evaluation of an oral self-emulsifying drug delivery system (SEDDS) for exenatide.
Menzel C; Holzeisen T; Laffleur F; Zaichik S; Abdulkarim M; Gumbleton M; Bernkop-Schnürch A
J Control Release; 2018 May; 277():165-172. PubMed ID: 29574041
[TBL] [Abstract][Full Text] [Related]
3. Hydrophobic ion pairing of a GLP-1 analogue for incorporating into lipid nanocarriers designed for oral delivery.
Ismail R; Phan TNQ; Laffleur F; Csóka I; Bernkop-Schnürch A
Eur J Pharm Biopharm; 2020 Jul; 152():10-17. PubMed ID: 32371152
[TBL] [Abstract][Full Text] [Related]
4. Oral self-emulsifying delivery systems for systemic administration of therapeutic proteins: science fiction?
Phan TNQ; Le-Vinh B; Efiana NA; Bernkop-Schnürch A
J Drug Target; 2019 Nov; 27(9):1017-1024. PubMed ID: 30776924
[No Abstract] [Full Text] [Related]
5. Self-emulsifying drug delivery systems: A versatile approach to enhance the oral delivery of BCS class III drug via hydrophobic ion pairing.
Asad M; Rasul A; Abbas G; Shah MA; Nazir I
PLoS One; 2023; 18(6):e0286668. PubMed ID: 37294790
[TBL] [Abstract][Full Text] [Related]
6. Impact of different hydrophobic ion pairs of octreotide on its oral bioavailability in pigs.
Bonengel S; Jelkmann M; Abdulkarim M; Gumbleton M; Reinstadler V; Oberacher H; Prüfert F; Bernkop-Schnürch A
J Control Release; 2018 Mar; 273():21-29. PubMed ID: 29355620
[TBL] [Abstract][Full Text] [Related]
7. Development and in vitro evaluation of a self-emulsifying drug delivery system (SEDDS) for oral vancomycin administration.
Zaichik S; Steinbring C; Caliskan C; Bernkop-Schnürch A
Int J Pharm; 2019 Jan; 554():125-133. PubMed ID: 30408530
[TBL] [Abstract][Full Text] [Related]
8. Development and in vitro characterization of self-emulsifying drug delivery system (SEDDS) for oral opioid peptide delivery.
Zupančič O; Rohrer J; Thanh Lam H; Grießinger JA; Bernkop-Schnürch A
Drug Dev Ind Pharm; 2017 Oct; 43(10):1694-1702. PubMed ID: 28589736
[TBL] [Abstract][Full Text] [Related]
9. Hydrophobic ion pair loaded self-emulsifying drug delivery system (SEDDS): A novel oral drug delivery approach of cromolyn sodium for management of bronchial asthma.
Asfour MH; Kassem AA; Salama A; Abd El-Alim SH
Int J Pharm; 2020 Jul; 585():119494. PubMed ID: 32505578
[TBL] [Abstract][Full Text] [Related]
10. Development, in vitro and in vivo evaluation of a self-emulsifying drug delivery system (SEDDS) for oral enoxaparin administration.
Zupančič O; Grieβinger JA; Rohrer J; Pereira de Sousa I; Danninger L; Partenhauser A; Sündermann NE; Laffleur F; Bernkop-Schnürch A
Eur J Pharm Biopharm; 2016 Dec; 109():113-121. PubMed ID: 27693677
[TBL] [Abstract][Full Text] [Related]
11. Improved Intestinal Mucus Permeation of Vancomycin via Incorporation Into Nanocarrier Containing Papain-Palmitate.
Efiana NA; Dizdarević A; Huck CW; Bernkop-Schnürch A
J Pharm Sci; 2019 Oct; 108(10):3329-3339. PubMed ID: 31136766
[TBL] [Abstract][Full Text] [Related]
12. Highly mucus permeating and zeta potential changing self-emulsifying drug delivery systems: A potent gene delivery model for causal treatment of cystic fibrosis.
Griesser J; Hetényi G; Federer C; Steinbring C; Ellemunter H; Niedermayr K; Bernkop-Schnürch A
Int J Pharm; 2019 Feb; 557():124-134. PubMed ID: 30594687
[TBL] [Abstract][Full Text] [Related]
13. Development and in vitro evaluation of an oral SEDDS for desmopressin.
Zupančič O; Leonaviciute G; Lam HT; Partenhauser A; Podričnik S; Bernkop-Schnürch A
Drug Deliv; 2016 Jul; 23(6):2074-83. PubMed ID: 26923905
[TBL] [Abstract][Full Text] [Related]
14. Self-emulsifying drug delivery systems (SEDDS): In vivo-proof of concept for oral delivery of insulin glargine.
Claus V; Spleis H; Federer C; Zöller K; Wibel R; Laffleur F; Dumont C; Caisse P; Bernkop-Schnürch A
Int J Pharm; 2023 May; 639():122964. PubMed ID: 37100259
[TBL] [Abstract][Full Text] [Related]
15. Novel self-emulsifying formulation of quercetin for improved in vivo antioxidant potential: implications for drug-induced cardiotoxicity and nephrotoxicity.
Jain S; Jain AK; Pohekar M; Thanki K
Free Radic Biol Med; 2013 Dec; 65():117-130. PubMed ID: 23792276
[TBL] [Abstract][Full Text] [Related]
16. Trypsin decorated self-emulsifying drug delivery systems (SEDDS): Key to enhanced mucus permeation.
Shahzadi I; Dizdarević A; Efiana NA; Matuszczak B; Bernkop-Schnürch A
J Colloid Interface Sci; 2018 Dec; 531():253-260. PubMed ID: 30036849
[TBL] [Abstract][Full Text] [Related]
17. Hydrophobic ion pairing: Key to highly payloaded self-emulsifying peptide drug delivery systems.
Griesser J; Hetényi G; Moser M; Demarne F; Jannin V; Bernkop-Schnürch A
Int J Pharm; 2017 Mar; 520(1-2):267-274. PubMed ID: 28188875
[TBL] [Abstract][Full Text] [Related]
18. Quality by Design-Based Development of Solid Self-Emulsifying Drug Delivery System (SEDDS) as a Potential Carrier for Oral Delivery of Lysozyme.
Šahinović M; Hassan A; Kristó K; Regdon G; Vranić E; Sovány T
Pharmaceutics; 2023 Mar; 15(3):. PubMed ID: 36986855
[TBL] [Abstract][Full Text] [Related]
19. Development and in vitro characterization of a papain loaded mucolytic self-emulsifying drug delivery system (SEDDS).
Leichner C; Menzel C; Laffleur F; Bernkop-Schnürch A
Int J Pharm; 2017 Sep; 530(1-2):346-353. PubMed ID: 28782582
[TBL] [Abstract][Full Text] [Related]
20. Comparative Analysis of PEG-Free and PEG-Based Self-Emulsifying Drug Delivery Systems for Enhanced Oral Bioavailability of Therapeutic (Poly) Peptides.
Haddadzadegan S; To D; Matteo Jörgensen A; Wibel R; Laffleur F; Bernkop-Schnürch A
Small; 2024 Feb; ():e2307618. PubMed ID: 38308358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
